Choose a language and wait for the translated text.
Speaker in this video:
Mr Loganathan S, AVP, Onesource Biopharma
Topic: The strategic shift: Why CDMOs are becoming central to pharma growth
Key Highlights:
[1] Drug delivery combinations are the fastest-growing CDMO segment, with US DDC sales rising 16% annually, driven mainly by GLP-1s and biologics.
[2] OneSource offers end-to-end capability, from cell line development through to drug device assembly and commercial manufacturing.
[3] OneSource combines strong technical acumen with worldwide quality and regulatory expertise across its manufacturing operations.
The post Mr Loganathan S, AVP, Onesource Biopharma appeared first on Express Pharma.
